Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Surgalign Holdings Inc SRGAQ

Healthcare Medical Instruments & Supplies
Surgalign Holdings, Inc. is a medical technology company. The Company is focused on developing artificial intelligence (AI) and augmented reality (AR) technology platform called HOLO AI, which is an AI software technology, which connects the continuum of care from the pre-op and clinical-stage through post-op care. Its HOLO Portal surgical guidance system, a component of its HOLO AI technology... see more

Recent & Breaking News (PINL:SRGAQ)

Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire June 3, 2022

Surgalign Holdings, Inc. Announces 1-for-30 Reverse Stock Split

GlobeNewswire May 16, 2022

Surgalign Holdings, Inc. Announces First Quarter 2022 Results and Raises Full Year 2022 Revenue Guidance Range

GlobeNewswire May 10, 2022

Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire May 6, 2022

Surgalign(TM) Announces the First Successful Surgical Procedure Utilizing its HOLO Portal(TM) Surgical Guidance System

GlobeNewswire May 5, 2022

Surgalign Holdings, Inc. Schedules First Quarter 2022 Earnings Release for May 10, 2022

GlobeNewswire April 26, 2022

Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire April 5, 2022

New EVoluSIon Study Data Demonstrates Strong Support for the SImmetry® Sacroiliac Joint Fusion System

GlobeNewswire March 24, 2022

Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2021 Results

GlobeNewswire March 15, 2022

Surgalign Holdings, Inc. Schedules Fourth Quarter and Full Year 2021 Earnings Release for March 15, 2022

GlobeNewswire March 8, 2022

Surgalign Announces Appointment of David Lyle as Chief Financial Officer

GlobeNewswire March 7, 2022

Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire March 4, 2022

Surgalign Holdings, Inc. Announces Pricing of $20 Million Public Offering

GlobeNewswire February 10, 2022

Surgalign Holdings, Inc. Announces Proposed Public Offering

GlobeNewswire February 10, 2022

Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire February 3, 2022

Surgalign Receives FDA Clearance for HOLO Portal(TM) System, the World's First AI-driven AR Guidance System for Spine Surgery and Reports Preliminary Fourth Quarter and Full Year 2021 Results

GlobeNewswire January 18, 2022

Surgalign Holdings, Inc. to Participate at the Sidoti Virtual Small Cap Conference

GlobeNewswire January 13, 2022

Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire January 6, 2022

Surgalign Holdings, Inc. Expands Digital Health Capabilities with Acquisition of a Significant Equity Interest in Inteneural Networks Inc.

GlobeNewswire January 5, 2022

Surgalign Holdings, Inc. to Present at the 2022 H.C. Wainwright Virtual BioConnect Conference

GlobeNewswire December 20, 2021